Related Experiment Videos
Direct antiviral agents and risk of HCC: Waiting for Godot
Calogero Cammà1, Gioacchino Leandro2
1Section of Gastroenterology, Biomedical Department of Internal and Specialized Medicine (Di.Bi.M.I.S.), University of Palermo, Italy.
Journal of Hepatology
|October 13, 2017
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Machine Learning Prediction of Liver Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
PNPLA3 polymorphisms and risk of hepatic and extrahepatic outcomes in MASLD: A meta-analysis of observational studies.
JHEP reports : innovation in hepatology·2026
Systemic therapy for HCC: Doublets, triplets and beyond.
Journal of hepatology·2026
Integrating systemic therapy in the earlier stages of liver cancer.
Journal of hepatology·2026
The use of locoregional therapies in cholangiocarcinoma.
Journal of hepatology·2026
Liver transplantation for primary liver cancers in the era of transplant oncology.
Journal of hepatology·2026
Advances in the imaging of liver cancer.
Journal of hepatology·2026
When democracies coerce their health professionals: institutional constraints and policy outcomes across four jurisdictions.
Frontiers in public health·2026
[Patient management and patient autonomy: An ethical tension?]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Governing beyond crisis: toward durable behavioral health reform.
Nature. Mental health·2026